PC-DAC: Exendin-4: Preliminary Phase I/II data

Preliminary data from a double-blind, multiple-dose, Canadian and U.S. Phase I/II trial in 70

Read the full 140 word article

How to gain access

Continue reading with a
two-week free trial.